• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0705
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Perforation (2001); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 01/25/2022
Event Type  Injury  
Event Description
Patient id: (b)(6).This is filed for pericardial effusion, requiring intervention.It was reported that this was a mitraclip procedure, performed to treat functional mitral regurgitation (mr) of grade 4.The septal puncture was performed and the steerable guide catheter (sgc) was inserted without issue.The clip delivery system (cds) was advanced and positioned.Grasping attempts were made and it was noted that the patient¿s blood pressure decreased.A pericardial effusion was noted.At this time, it was noted that good leaflet insertion was noted and the clip was implanted.Pericardiocentesis was performed.The pericardial fluid continued to drain; therefore, the decision was made to place an atrial septal occluder.After the occluder was placed, the pericardial effusion resolved with time and the blood pressure stabilized.The procedure was completed, with implant of one clip and the mr reduced to grade 1.No additional information was provided.
 
Manufacturer Narrative
The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Patient id: (b)(6).This is filed for pericardial effusion, requiring intervention.It was reported that this was a mitraclip procedure, performed to treat functional mitral regurgitation (mr) of grade 4.The septal puncture was performed and the steerable guide catheter (sgc) was inserted without issue.The clip delivery system (cds) was advanced and positioned.Grasping attempts were made and it was noted that the patient¿s blood pressure decreased.A pericardial effusion was noted.At this time, it was noted that good leaflet insertion was noted and the clip was implanted.Pericardiocentesis was performed.The pericardial fluid continued to drain; therefore, the decision was made to place an atrial septal occluder.After the occluder was placed, the pericardial effusion resolved with time and the blood pressure stabilized.The procedure was completed, with implant of one clip and the mr reduced to grade 1.No additional information was provided.
 
Event Description
Subsequent to the initial report, additional information was received.Cardiac tamponade occurred with the pericardial effusion.Pericardiocentesis was performed, and then an atrial septal occluder was placed.The event resolved on 02/17/2022.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of perforation, cardiac tamponade, pericardial effusion, and hypotension as listed in the instructions for use (ifu), are known possible complications associated with mitraclip procedures.Based on available information, a cause for the reported perforation, pericardial effusion and cardiac tamponade could not be determined.The reported hypotension is cascading event of reported pericardial effusion and cardiac tamponade.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13552226
MDR Text Key285822617
Report Number2024168-2022-01663
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/04/2022
Device Catalogue NumberSGC0705
Device Lot Number10805R249
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient SexMale
Patient Weight67 KG
-
-